1. Multiple sclerosis at the crossroads of scientific evidence and clinical translation

   • Johann Sellner

   editorial 26 October 2022 Pages: 327 - 328

2. Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects

   • Elisabeth Olbert
   • Walter Struhal

   main topic Open access 28 March 2022 Pages: 329 - 336

   

3. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity

   • Harald Hegen
   • Klaus Berek
   • Florian Deisenhammer

   main topic Open access 08 February 2022 Pages: 337 - 345

   

4. Experimental laboratory biomarkers in multiple sclerosis

   • Borros Arneth
   • Jörg Kraus

   main topic 07 March 2022 Pages: 346 - 358

   

5. An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis

   • Arkady Ovchinnikov
   • Oliver Findling

   main topic 20 June 2022 Pages: 359 - 364

6. Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety

   • Tobias Moser
   • Tjalf Ziemssen
   • Johann Sellner

   main topic Open access 22 April 2022 Pages: 365 - 372

7. Natalizumab treatment during pregnancy in multiple sclerosis—clinical and bioethical aspects of an ongoing debate

   • Klaus Berek
   • Claudia Paganini
   • Franziska Di Pauli

   main topic 10 February 2022 Pages: 373 - 378

   

8. Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever

   • Constanze Trostel
   • Kornelia Laichinger
   • Markus C. Kowarik

   main topic Open access 03 November 2021 Pages: 379 - 382

   

9. Neuer Masterstudiengang: Multiple Sklerose Management

   • Isabel Voigt
   • Christine Stadelmann
   • Tjalf Ziemssen

   themenschwerpunkt 02 February 2022 Pages: 383 - 391